ALEXIS COURVILLE: Open Payments
NPI 1831870948 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,300 in 149 payments from 15 companies in 2025. Trend: 2023 $185 · 2024 $1,911 · 2025 $2,300
Food & beverage: $2,202Education: $98
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $392 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $345 |
| ABBVIE INC. | 28 | $316 |
| Otsuka America Pharmaceutical, Inc. | 21 | $238 |
| Alkermes, Inc. | 17 | $221 |
| Neurocrine BioSciences, Inc. | 10 | $189 |
| Janssen Pharmaceuticals, Inc | 8 | $143 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Indivior Inc. | 3 | $74 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, INGREZZA, UZEDY, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across LA — which companies pay providers there.
